Gary Borzillo

950 total citations
24 papers, 737 citations indexed

About

Gary Borzillo is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Gary Borzillo has authored 24 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Gary Borzillo's work include Immunotherapy and Immune Responses (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Gary Borzillo is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Gary Borzillo collaborates with scholars based in United States, Spain and Netherlands. Gary Borzillo's co-authors include Charles J. Sherr, RA Ashmun, Blaise Lippa, Yoshihide Tsujimoto, Robert Millham, Brett E. Houk, Kristen J. Pierce, Michael J. Munchhof, Nandini C. Patel and Tracey Boyden and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular and Cellular Biology.

In The Last Decade

Gary Borzillo

22 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary Borzillo United States	12	492	169	147	95	93	24	737
Lee Wisner United States	8	216 0.4×	194 1.1×	117 0.8×	88 0.9×	46 0.5×	21	544
Gábor Barna Hungary	15	387 0.8×	173 1.0×	153 1.0×	48 0.5×	119 1.3×	64	711
Masamichi Mori Japan	17	524 1.1×	407 2.4×	189 1.3×	164 1.7×	131 1.4×	41	1.1k
Leslie Giampa United States	11	346 0.7×	136 0.8×	192 1.3×	43 0.5×	75 0.8×	13	783
A M Martelli Italy	10	580 1.2×	191 1.1×	89 0.6×	37 0.4×	91 1.0×	17	785
Elisabeth Walsby United Kingdom	14	308 0.6×	216 1.3×	83 0.6×	66 0.7×	131 1.4×	25	559
Scott Ackler United States	8	472 1.0×	233 1.4×	75 0.5×	45 0.5×	76 0.8×	10	625
Kristina West United States	9	646 1.3×	187 1.1×	69 0.5×	25 0.3×	87 0.9×	12	819
Josep Lluís Parra United Kingdom	5	798 1.6×	352 2.1×	99 0.7×	152 1.6×	121 1.3×	6	1.1k
Andrea Ghelli Luserna di Rorà Italy	13	513 1.0×	303 1.8×	76 0.5×	64 0.7×	63 0.7×	38	735

Countries citing papers authored by Gary Borzillo

Since Specialization

Citations

This map shows the geographic impact of Gary Borzillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Borzillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Borzillo more than expected).

Fields of papers citing papers by Gary Borzillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Borzillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Borzillo. The network helps show where Gary Borzillo may publish in the future.

Co-authorship network of co-authors of Gary Borzillo

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Borzillo. A scholar is included among the top collaborators of Gary Borzillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Borzillo. Gary Borzillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hüneburg, Robert, Marcia Cruz‐Correa, Evelien Dekker, et al.. (2023). Lorpucitinib (JNJ-64251330) in patients with familial adenomatous polyposis (FAP): Results from a phase 1b study.. Journal of Clinical Oncology. 41(16_suppl). 10514–10514. 1 indexed citations

Ma, Xuewen, Gary Borzillo, Gerald Chu, et al.. (2023). A Phase I, Randomized, Multi‐Dose Study to Evaluate the Enteric Selectivity and Safety of JAK Inhibitor, Lorpucitinib, in Healthy Participants. Clinical Pharmacology & Therapeutics. 115(5). 1075–1084.

Smith, Alexis K., et al.. (2018). JNJ-64457107, a CD40 Agonist, Induces Cell Death in BCL6hiIRF4neg GCB Subtype of DLBCL. Blood. 132(Supplement 1). 1674–1674. 1 indexed citations

Shapiro, Geoffrey I., Katherine M. Bell‐McGuinn, Julian R. Molina, et al.. (2015). First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer. Clinical Cancer Research. 21(8). 1888–1895. 97 indexed citations

Britten, Carolyn D., Alex A. Adjei, Robert Millham, et al.. (2014). Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer. Investigational New Drugs. 32(3). 510–517. 66 indexed citations

Dowsett, Mitch, María Koehler, Robert Millham, et al.. (2012). 104P Phase II Randomized Study of Pre-Operative Pf-04691502 Plus Letrozole Compared with Letrozole (L) In Patients with Estrogen Receptor-Positive, Her2-Negative Early Breast Cancer (Bc). Annals of Oncology. 23. ii44–ii44. 5 indexed citations

Millham, Robert, Brett E. Houk, Gary Borzillo, et al.. (2011). Abstract A167: First-in-patient study of PF-05212384, a small molecule intravenous dual inhibitor of PI3K and mTOR in patients with advanced cancer: Update on safety, efficacy, and pharmacology.. Molecular Cancer Therapeutics. 10(11_Supplement). A167–A167. 13 indexed citations

Reynolds, Jennifer M., et al.. (2009). Abstract B119: Insulin-like growth factor 1 receptor mutants are inhibited by figitumumab (CP-751, 871) in vitro. Molecular Cancer Therapeutics. 8(12_Supplement). B119–B119. 2 indexed citations

Lippa, Blaise, Gonghua Pan, Matthew S. Corbett, et al.. (2008). Synthesis and structure based optimization of novel Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(11). 3359–3363. 64 indexed citations

10.

Sherr, Charles J., Jun‐ya Kato, Gary Borzillo, James R. Downing, & Martine F. Roussel. (2007). Signal‐Response Coupling Mediated by the Transduced Colony‐Stimulating Factor‐1 Receptor and its Oncogenic fms Variants in Naive Cells. Novartis Foundation symposium. 148. 96–109.

11.

Borzillo, Gary & Blaise Lippa. (2005). The Hedgehog Signaling Pathway as a Target for Anticancer Drug Discovery. Current Topics in Medicinal Chemistry. 5(2). 147–157. 50 indexed citations

12.

Borzillo, Gary. (2005). Akt and emerging models for tumor cell energetics. Drug Discovery Today Therapeutic Strategies. 2(4). 331–336. 2 indexed citations

13.

Borzillo, Gary, et al.. (1997). Transforming growth factor-β3 protection of epithelial cells from cycle-selective chemotherapy in vitro. Biochemical Pharmacology. 53(8). 1149–1159. 26 indexed citations

14.

Borzillo, Gary. (1997). A p53 growth arrest protects fibroblasts from anticancer agents. Frontiers in bioscience. 2(1). a37–45. 1 indexed citations

15.

Burrows, Peter D., et al.. (1991). Differences in Human B Cell Differentiation. Advances in experimental medicine and biology. 292. 215–226. 2 indexed citations

16.

Sherr, Charles J., Gary Borzillo, Jun‐ya Kato, et al.. (1991). Regulation of cell growth and differentiation by the colony-stimulating factor 1 receptor.. PubMed. 28(2). 143–51. 8 indexed citations

17.

Borzillo, Gary, Richard A. Ashmun, & Charles J. Sherr. (1990). Macrophage Lineage Switching of Murine Early Pre-B Lymphoid Cells Expressing Transduced fms Genes. Molecular and Cellular Biology. 10(6). 2703–2714. 29 indexed citations

18.

Borzillo, Gary, RA Ashmun, & Charles J. Sherr. (1990). Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes.. Molecular and Cellular Biology. 10(6). 2703–2714. 108 indexed citations

19.

Borzillo, Gary & Charles J. Sherr. (1989). Early Pre-B-Cell Transformation Induced by the v-fms Oncogene in Long-Term Mouse Bone Marrow Cultures. Molecular and Cellular Biology. 9(9). 3973–3981. 7 indexed citations

20.

Borzillo, Gary & Charles J. Sherr. (1989). Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures.. Molecular and Cellular Biology. 9(9). 3973–3981. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact